RxDoctor Payments Data

Eric Marvin, DO

Neurological Surgery · Roanoke, VANPI 1407016082

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,050 of the $11,976 with a category attached, or 67.2%. Medical Device Business Services, Inc. accounts for 81.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $8,142 and has fallen 97.9% since, to $174 in 2025.

$11,976in general payments, 2019–2025

Across 35 payments — averaging $342.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$10K
  • Johnson & Johnson$989
  • Medtronic$605
  • Integra Lifesciences Corporation$203
  • Stryker$164
  • GT Medical Technologies, Inc$95
  • plus $148 from 4 others
$15,928in research payments, 2019–2025

Across 1 payment — averaging $15,928 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$16K

What the payments were for

  • Consulting fees$8,05067%
  • Travel & lodging$1,69414%
  • Food & beverage$2,23219%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,976 in reported general payments places this provider in the 75th percentile of 156 neurological surgery providers in Virginia.

See all neurological surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$353,597
Medicare patients
583
Services billed
1,302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin17$233

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →